Palantir Q2 Earnings Crush Expectations: Revenue Up 93%, Guidance Raised Sharply
Palantir locked in a record $2.13B of US commercial contracts in Q2, up 153% YoY. Total TCV reached $3.37B with $6.24B remaining deal value.
Palantir locked in a record $2.13B of US commercial contracts in Q2, up 153% YoY. Total TCV reached $3.37B with $6.24B remaining deal value.
Yum Brands (YUM) stock drops as two Michigan deaths link to the largest US cyclospora outbreak tied to Taco Bell lettuce. Over 20,000 cases reported.
FAA approves Boeing’s 737-7, the smallest and longest-range MAX jet. 135-160 seats, 3,800 nm range. Southwest prepares for first deliveries.
AMC and Cinemark set all-time box-office records as “Spider-Man: Brand New Day” opens to $927M globally and $355M domestically, boosting IMAX and MCS as well.
Twist Bioscience shares rose after record $118.4M Q3 revenue (+23% YoY), 14th sequential growth quarter, raised FY26 outlook, and path to EBITDA breakeven.
Krystal Biotech shares dropped after Q2 revenue missed forecasts, despite strong earnings, growth, and progress with VYJUVEK sales.